bpc-157 fda approved status A wins still a win An FDA advisory panel voted

No COA report currently listed for this product/batch

The BPC-157/TB-500 blend, often called the "Wolverine Stack," combines two synthetic peptides designed to accelerate injury recovery

Though further research is underway on the MTHFR gene, its been suggested that those with this gene mutation resulting in hyperhomocysteinemia may experience issues with: Inflammation Memory Immunity Migraines Depression Cognition Sleep By restoring some of the common vitamin/nutrient deficiencies seen in this condition, homocysteine levels may begin to decrease, resulting in an improvement in some of these symptoms

Oral B12 supplements often contain higher levels than the recommended daily allowance (RDA)